A Randomized, Controlled, Phase 1-2 Open Label Study of ST266 IV Administration to Assess the Safety, Tolerability, and Preliminary Efficacy of ST266 in Infants with Necrotizing Enterocolitis.
Clinical Trial Grant
Administered By
Pediatrics, Neonatology
Awarded By
Noveome Biotherapeutics, Inc.
Start Date
April 16, 2024
End Date
October 28, 2025
Administered By
Pediatrics, Neonatology
Awarded By
Noveome Biotherapeutics, Inc.
Start Date
April 16, 2024
End Date
October 28, 2025